Cost-effectiveness of a hypothetical cell or gene therapy cure for sickle cell disease
Abstract Sickle cell disease (SCD) is a group of inherited genetic conditions associated with lifelong complications and increased healthcare resource utilization. Standard treatment for SCD in the US varies based on stage of the disease and observed clinical severity. In this study, we aim to evalu...
Guardado en:
Autores principales: | Jonathan Salcedo, Jenniffer Bulovic, Colin M. Young |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/538cdffe961341efbf57f399ebeb6a38 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Profile of Medicaid enrollees with sickle cell disease: A high need, high cost population.
por: April Grady, et al.
Publicado: (2021) -
Profile of Medicaid enrollees with sickle cell disease: A high need, high cost population
por: April Grady, et al.
Publicado: (2021) -
Pilot program of newborn screening for sickle cell disease in angola- Angola Sickle Cell Initiative (ASCI)
por: D. Nirenberg, et al.
Publicado: (2015) -
Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium.
por: Rita V Masese, et al.
Publicado: (2021) -
Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium
por: Rita V. Masese, et al.
Publicado: (2021)